• Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

4453 Total Publications

Registration of Images With Varying Topology Using Embedded Maps
Xiaoxing Li, Xiaojing Long, Laurienti, P., & Wyatt, C.
PMID: 22194239 ; 2012; Journal IEEE Transactions on Medical Imaging; vol. 31; no. 3; pp. 749-765; doi:10.1109/TMI.2011.2178609
Is radiological evaluation as good as computer-based volumetry to assess hippocampal atrophy in Alzheimer's disease?
Boutet, C, Chupin, M, Colliot, O, Sarazin, M, Mutlu, G, Drier, A, Pellot, A, Dormont, D and Lehéricy, S
2012; Journal Neuroradiology; vol. 54; no. 12; pp. 1321-30;
The interleukin 3 gene (IL3) contributes to human brain volume variation by regulating proliferation and survival of neural progenitors
Luo, XJ, Li, M, Huang, L, Nho, K, Deng, M, Chen, Q, Weinberger, DR, Vasquez, AA, Rijpkema, M, Mattay, VS, Saykin, AJ, Shen, L, Fern√°ndez, G, Franke, B, Chen, JC, Chen, XN, Wang, JK, Xiao, X, Qi, XB, Xiang, K, Peng, YM, Cao, XY, Li, Y, Shi, XD, Gan, L and Su, B
2012; Journal PLoS One; vol. 7; no. 11; pp. e50375;
Structural brain alterations before mild cognitive impairment in ADNI: validation of volume loss in a predefined antero-temporal region.
Smith, C. D., Andersen, A. H., & Gold, B. T.
2012; Journal Journal of Alzheimer's Disease; vol. 3; no. 3; pp. S49-58; doi:10.3233/JAD-2012-120157
Risk classification in mild cognitive impairment patients for developing Alzheimer’s disease.
Zhou, B., Nakatani, E., Teramukai, S., Nagai, Y., & Fukushima, M.
2012; Journal Journal of Alzheimer's Disease; vol. 30; no. 2; pp. 367-75; doi:10.3233/JAD-2012-112117
Identification of gene pathways implicated in Alzheimer’s disease using longitudinal imaging phenotypes with sparse regression.
Silver, M., Janousova, E., Hua, X., Thompson, P. M., & Montana, G.
2012; Journal Neuroimage; vol. 63; no. 3; pp. 1681-1694; doi:10.1016/j.neuroimage.2012.08.002
Resting state FDG-PET functional connectivity as an early biomarker of Alzheimer’s disease using conjoint univariate and independent component analyses.
Toussaint, P. J., Perlbarg, V., Bellec, P., Desarnaud, S., Lacomblez, L., Doyon, J., … Benali, H.
2012; Journal Neuroimage; vol. 63; no. 2; pp. 936-946; doi:10.1016/j.neuroimage.2012.03.091
Practical management of heterogeneous neuroimaging metadata by global neuroimaging data repositories.
Neu, S. C., Crawford, K. L., & Toga, A. W.
2012; Journal Frontiers in Neuroinformatics; vol. 6; pp. 8; doi:10.3389/fninf.2012.00008
Plasma proteomics for the identification of Alzheimer disease.
Guo, L.-H., Alexopoulos, P., Wagenpfeil, S., Kurz, A., & Perneczky, R.
2012; Journal Alzheimer's Disease and Associated Disorders; vol. 27; no. 4; pp. 337-42; doi:10.1097/WAD.0b013e31827b60d2
Metabolic brain covariant networks as revealed by FDG-PET with reference to resting-state fMRI networks.
Di, X., Biswal, B. B., & Alzheimer’s Disease Neuroimaging, I.
2012; Journal Brain Connect; vol. 2; no. 5; pp. 275-283; doi:10.1089/brain.2012.0086